Does a code break reveal the whole randomization list?

It should disclose the information needed for the authorized purpose; an individual event does not automatically justify trial-wide disclosure.

Must a sponsor approve every emergency code break before it happens?

Procedures must avoid delaying necessary emergency unblinding; UK MHRA guidance specifically rejects sponsor contact as a barrier in that setting.

Is a participant's data automatically unusable afterward?

No. Record the event and assess its implications through the prespecified analysis and follow-up framework.

AI Glossary / Statistics and probability / Intermediate

Code-break procedure

Definition

A code-break procedure is a documented process for revealing a blinded trial participant's assigned intervention when authorized circumstances require it. In clinical research, the code links a participant or treatment identifier to the actual allocation. Emergency unblinding may be necessary when that information is relevant to clinical management. The procedure should enable timely access while limiting unnecessary disclosure and recording what happened.

What it means

Blinding reduces the influence of treatment knowledge on behavior, care and outcome assessment. A code-break process recognizes that participant safety can require selected people to learn an allocation before the planned end of blinding. This is controlled disclosure, not cryptographic code cracking or a software debugging technique. Revealing one participant's allocation does not necessarily require revealing every allocation or informing every trial team member. The scope depends on the need, protocol and applicable arrangements.

How it works

Before recruitment, the trial establishes who can access allocation information, how identities are verified, what systems or backup arrangements are available and how events are documented. An authorized clinician can obtain the relevant allocation when needed for participant care without avoidable delay. The record should identify the participant, reason, date, person accessing the information and recipients of the disclosure. Trial personnel then assess reporting and follow-up obligations under the protocol and applicable requirements. Access controls should preserve blinding for people who do not need the information, while contingency arrangements address unavailable systems or out-of-hours access.

Three practical examples

Clinical emergency: a treating investigator obtains an individual allocation when knowledge of the assigned intervention is relevant to immediate management.
Trial-system testing: staff rehearse the authorized unblinding route using test records before recruitment begins.
Data-quality review: the team reconciles access logs with documented unblinding events and investigates an unexplained disclosure.

Think of it this way

Think of an emergency information envelope held under controlled access. Its purpose is to make essential information available when genuinely needed, not to make the information impossible to reach. A useful procedure combines availability with a clear record of who opened it and why. Electronic systems implement the same underlying balance.

Worked example

Suppose a fictional trial has 240 randomized participants. Three different participants undergo documented emergency code breaks before the planned analysis. The participant-level early-unblinding proportion is 3/240 = 1.25%, leaving 237 participants without a recorded individual code break at that point. One of the three records is accessed twice by authorized clinicians, so the system contains four access events but only three affected participants. Reporting four divided by 240 as the participant-unblinding proportion would mix events with people. These counts do not measure whether every assessor stayed blinded: one disclosure could reach several people, and accidental disclosures might require separate reconciliation. They also do not determine whether an event was justified or whether the trial result is biased.

Illustrative case study

Fictional case: Elm Research is preparing a blinded study supported by an electronic trial platform. During a rehearsal, an investigator discovers that the emergency access route depends on an unavailable central administrator. The team corrects the access arrangements and verifies a documented fallback before recruitment. It also checks that ordinary dashboards and automated summaries do not reveal allocation to blinded assessors. Later, a legitimate individual code break is documented with restricted distribution. This invented case illustrates operational preparation and information control; it is not a clinical recommendation or evidence about a real trial.

Common misconceptions and mistakes

Maintaining blinding must not become a reason to delay necessary care. Conversely, routine curiosity about an outcome is not a sound basis for unrestricted early disclosure. A code break is not synonymous with withdrawing a participant, stopping all follow-up or deleting their data. Those are separate decisions governed by the protocol, consent and circumstances. Knowing the allocation cannot be undone simply by removing it from a screen. Distinguish planned final unblinding, emergency individual unblinding and accidental disclosure, because their timing and implications differ.

Business use

Organizations building clinical-research software need to treat code breaking as a defined workflow with tested access, auditability and contingency arrangements. AI summarization can accidentally propagate allocation from restricted records into documents seen by blinded staff. Review permissions and output destinations with that risk in mind, and keep automated assistance within the approved clinical and trial processes. Performance measures should assess successful authorized retrieval and appropriate disclosure control rather than reward a low code-break count in isolation. A low count could reflect an inaccessible system rather than good trial conduct.

Check your understanding

Why does the worked example distinguish four access events from three participants?

Answer: One participant's allocation was accessed twice. Event counts describe system use, while the participant-level proportion counts unique affected people. Neither count alone establishes the extent of knowledge among trial staff or the impact on outcome assessment.

Related terms

Allocation concealment
Clinical trial
Blinding
unblinding
randomization code
audit trail
emergency access
trial protocol
outcome assessment
role-based access control

Learn next

distinguish allocation concealment before assignment from blinding after assignment. Study how trial protocols define emergency disclosure, reporting and analysis of deviations. For digital systems, map who can see each output and test backup access under realistic conditions. Review the applicable trial guidance rather than assuming that one organization's procedure applies everywhere.

Allocation concealment

Sources

MHRA, Common issues: Clinical, emergency unblinding: https://www.gov.uk/government/publications/common-issues-identified-during-clinical-trial-applications/common-issues-clinical MHRA, Clinical trials for medicines: collection, verification and reporting of safety events: https://www.gov.uk/guidance/clinical-trials-for-medicines-collection-verification-and-reporting-of-safety-events University Hospitals Bristol, Pharmacy SOPs, emergency code-break procedure listing: https://www.uhbristol.nhs.uk/research-innovation/for-researchers/templates-and-sops/sops/pharmacy-sops/

Previous: Codd's 12 rules Next: Code-excited linear prediction